CAMELLINO, DARIO
 Distribuzione geografica
Continente #
EU - Europa 3.478
AS - Asia 549
NA - Nord America 215
SA - Sud America 57
AF - Africa 18
OC - Oceania 2
Totale 4.319
Nazione #
IT - Italia 3.416
SG - Singapore 217
US - Stati Uniti d'America 206
CN - Cina 159
VN - Vietnam 112
BR - Brasile 32
FR - Francia 26
HK - Hong Kong 20
AR - Argentina 10
DE - Germania 9
MX - Messico 8
BD - Bangladesh 7
CL - Cile 6
ID - Indonesia 6
ZA - Sudafrica 6
FI - Finlandia 5
GB - Regno Unito 5
IQ - Iraq 5
IN - India 4
CH - Svizzera 3
CO - Colombia 3
EC - Ecuador 3
MA - Marocco 3
PH - Filippine 3
AU - Australia 2
EG - Egitto 2
GH - Ghana 2
IE - Irlanda 2
NL - Olanda 2
NP - Nepal 2
OM - Oman 2
PK - Pakistan 2
PY - Paraguay 2
RU - Federazione Russa 2
TN - Tunisia 2
AZ - Azerbaigian 1
CA - Canada 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HU - Ungheria 1
JP - Giappone 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
NE - Niger 1
PL - Polonia 1
PT - Portogallo 1
QA - Qatar 1
RE - Reunion 1
SE - Svezia 1
TH - Thailandia 1
TR - Turchia 1
UA - Ucraina 1
VE - Venezuela 1
Totale 4.319
Città #
Genova 1.384
Genoa 1.330
Vado Ligure 391
Rapallo 282
Singapore 107
San Jose 74
Ashburn 35
Ho Chi Minh City 30
Lauterbourg 24
Hanoi 21
Beijing 19
Hong Kong 18
New York 12
Council Bluffs 10
St Louis 10
Bordighera 9
Mexico City 7
Santa Clara 7
Da Nang 6
Milan 6
Biên Hòa 4
Los Angeles 4
Tianjin 4
Frankfurt am Main 3
Haiphong 3
Helsinki 3
Hải Dương 3
Johannesburg 3
Ninh Bình 3
Schiffdorf 3
Zurich 3
Accra 2
Buenos Aires 2
Bắc Giang 2
Bến Tre 2
Can Tho 2
Cardiff 2
Chennai 2
Contagem 2
Florence 2
Guayaquil 2
Karbala 2
Lappeenranta 2
Nha Trang 2
Orem 2
Rio de Janeiro 2
Rome 2
Santiago 2
Thái Bình 2
Tân Tiến 2
Viamão 2
Điện Bàn 2
Agadir 1
Altamonte Springs 1
Amsterdam 1
Aparecida 1
Ashland 1
Asyut 1
Atlanta 1
Baghdad 1
Baku 1
Balikpapan 1
Batna City 1
Belo Horizonte 1
Biñan 1
Boardman 1
Bosa 1
Brasília 1
Budapest 1
Buin 1
Buon Ma Thuot 1
Bình Dương 1
Bắc Ninh 1
Cagliari 1
Cairo 1
Cajamar 1
Campagnano di Roma 1
Campinas 1
Cape Town 1
Capitão Poço 1
Caracas 1
Casablanca 1
Catalão 1
Catanduva 1
Chandīgarh 1
Changshu 1
Chicago 1
Chieti 1
City of London 1
Ciudad del Este 1
Cologne 1
Comodoro Rivadavia 1
Copenhagen 1
Corona 1
Curitiba 1
Dallas 1
Dehradun 1
Doha 1
Dublin 1
Fes 1
Totale 3.908
Nome #
A Positron Emission Tomography/Computed Tomography (PET/CT) Evaluation of Asymptomatic Abdominal Aortic Aneurysms: Another Point of View. 222
Cardiovascular diseases in patients with rheumatoid arthritis: comment on the article by Koivuniemi et al. 182
Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography 181
Dissecting the inflammatory response in polymyalgia rheumatica: the relative role of IL-6 and its inhibition 176
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis 169
Seronegative spondyloarthropathies: what radiologists should know 150
Ankylosis of the wrist bones in patients with rheumatoid arthritis: a study with extremity-dedicated MRI 148
High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography 148
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 142
Systemic vascular inflammation in abdominal aortic aneurysm patients: a contrast-enhanced PET/CT study 135
2015 Recommendations for the Management of Polymyalgia Rheumatica: A European League Against Rheumatism/American College of Rheumatology Collaborative Initiative 132
11. Steroid schedules in PMR 131
FRI0480 CHANGES IN CIRCULATING SCTLA-4 FOLLOWING ZOLEDRONIC ACID INFUSION 130
Methotrexate treatment of polymyalgia rheumatica/giant cell arteritis-associated large vessel vasculitis. 118
Seronegative spondyloarthritis and Darier's disease: more than a casual association? 117
IMAGING AND SEROLOGICAL PROFILING OF PATIENTS WITH POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS 117
Cardiac and aortic involvement in patients with polymyalgia rheumatica: a study with echocardiography and FDG-PET/CT 111
The multifaceted pathogenesis of polymyalgia rheumatica/giant cell arteritis. 108
Imaging in arthritis: quantifying effects of therapeutic intervention using MRI and molecular imaging. 107
[Polymyalgia rheumatica and aortic involvement]. 106
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 102
Clinical and FDG-PET/CT correlates in patients with polymyalgia rheumatica 94
AB0354 FDG-PET-DETECTED LARGE VESSEL VASCULITIS DOES NOT PREDICT DISEASE OUTCOME IN PATIENTS WITH GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA 87
Zoledronate decreases CTLA-4 in vivo and in vitro independently of its action on bone resorption 86
Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia rheumatica, giant cell arteritis and fever of unknown origin 83
Extrusion of the medial meniscus in knee osteoarthritis assessed with a rotating clino-orthostatic permanent-magnet MRI scanner 71
AB1289 HIGHER BASELINE FDG JOINT UPTAKE AT PET/CT IS ASSOCIATED WITH A HIGHER REMISSION RATE IN POLYMYALGIA RHEUMATICA: A RETROSPECTIVE 3-YEAR OBSERVATIONAL STUDY 64
Seasonal onset of polymyalgia rheumatica: correlations with the pattern of clinical presentation, disease severity and outcome in 383 patients from a single centre. 63
Management of giant cell arteritis among general practitioners from Genoa, Italy: a web-based survey. 63
Involvement of different knee structures reveleated by PET-CT in polymyalgia rheumatica 63
Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review 61
A seasonal pattern in the onset of polymyalgia rheumatica and giant cell arteritis? A systematic review and meta-analysis 54
Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: A systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica 51
Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides 51
The provisional OMERACT ultrasonography score for giant cell arteritis 45
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis 44
British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: Executive summary 41
Soluble Co‐Inhibitory Immune Checkpoint Molecules Are Increased in Patients With Polymyalgia Rheumatica Without Significant Correlations With Clinical Status: A Case‐Control Study 41
Are the new ACR/EULAR criteria the ultimate answer for polymyalgia rheumatica classification? 38
FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC 37
[Polymyalgia rheumatica: diagnostic and therapeutic issues of an apparently straightforward disease.] 34
Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica 34
From polymyalgia arteritica to arteritis polymyalgica: redefining the GCA-PMR spectrum through advanced MRI insights 29
Treat to Target: A Valid Concept for Management of Polymyalgia Rheumatica and Giant Cell Arteritis? 25
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis 23
Update on treatment of polymyalgia rheumatica 23
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data 22
AB0683 Treatment with statins in patients studied by fdg-pet/ct for possible large vessel vasculitis is associated with a low vascular score 20
Should 18F-FDG-PET imaging be used in the diagnosis of GCA? 17
Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica 16
Large vessel vasculitis: Which imaging method? 14
Large vessel vasculitis: Is it more common than usually assumed? 14
New insights into the role of imaging in polymyalgia rheumatica 13
Reply to: What could a new disease activity score for polymyalgia rheumatica do better? 13
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force 13
Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica 12
SAT0215 Twelve Year Follow-Up on Progression of Nailfold Microangiopathy Detected through Transition between Different Capillaroscopic Patterns of Microvascular Damage in Systemic Sclerosis 9
THU0454 Increased fdg uptake of the muscles in polymyalgia rheumatica (PMR) 6
FRI0033 TNFalpha Production In Cultured Human Macrophages after CTLA4-IG (abatacept) In Vitro Treatment 6
FRI0369 Pattern of Clinical Presentation and Disease Severity in Patients with Polymyalgia Rheumatica 5
Totale 4.417
Categoria #
all - tutte 14.789
article - articoli 13.929
book - libri 0
conference - conferenze 480
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202157 0 0 0 0 0 0 0 0 0 21 19 17
2021/2022286 5 18 12 33 13 26 17 69 21 27 5 40
2022/2023332 28 61 3 24 40 47 3 18 42 5 61 0
2023/2024234 3 40 4 32 18 27 13 16 6 5 13 57
2024/2025925 21 115 32 65 105 95 66 160 14 30 88 134
2025/20261.499 215 52 189 164 196 95 207 71 163 147 0 0
Totale 4.417